| Literature DB >> 28064425 |
Swetha Ettireddy1, Vijitha Chandupatla1, Ciddi Veeresham2.
Abstract
Among the microorganisms employed in the study, Aspergillus niger (GUFCC5443), Escherichia coli (ATCC9637), Streptomyces halstedii (CKM-2), Pseudomonas putida (NCIB9494), Cunninghamella elegans (NCIM689) and Sphingomonas paucimobilis (NCTC11030) were capable for the enantioselective conversion of racemic Carvedilol. Immobilization technique enhanced the enantioselectivity of microorganisms and thus increased the enantiomeric purity of the drug. Excellent enantiomeric ratios (E) were found in reactions catalyzed by immobilized A. niger and E. coli with values 174.44 and 104.26, respectively. Triacylglycerol lipase from Aspergillus niger was also employed in this study as a biocatalyst which resulted in the product with 83.35% enantiomeric excess (ee) and E of 11.34 while the enzyme on immobilization has yielded 99.08% ee and 216.39 E. The conversion yield (C%) of the drug by free-enzyme was 57.42%, which was enhanced by immobilization to 90.51%. Hence, our results suggest that immobilized triacylglycerol lipase from A. niger (Lipase AP6) could be an efficient biocatalyst for the enantioselective resolution of racemic Carvedilol to (S)-(-)-Carvedilol with high enantiomeric purity followed by immobilized cultures of A. niger and E. coli.Entities:
Keywords: Carvedilol; Immobilization; Stereoinversion; Triacylglycerol lipase; Whole-cell microorganisms
Year: 2017 PMID: 28064425 PMCID: PMC5315674 DOI: 10.1007/s13659-016-0118-2
Source DB: PubMed Journal: Nat Prod Bioprospect ISSN: 2192-2209
Fig. 1Chromatogram of racemic Carvedilol (1 µg/mL) [R(+)-Carvedilol and S(−)-Carvedilol]
Fig. 2Chromatograms of Carvedilol after incubation with whole-cell cultures and free-enzyme. a Sphingomonas paucimobilis; b C. elegans; c P. putida; d Streptomyces halstedii; e E. coli; f A. niger; g Lipase AP6 enzyme
Enantioselective conversion of Carvedilol after incubation with the whole-cell as well as immobilized-cell cultures for 10 days
| S. no | Microorganism | Whole-cell incubation | Immobilized-cell incubation | ||||
|---|---|---|---|---|---|---|---|
| ee (%) | E | C (%) | ee (%) | E | C (%) | ||
| 1 |
| 82.13 | 10.19 | 87.95 | 98.86 | 174.44 | 66.31 |
| 2 |
| 76.07 | 7.36 | 14.52 | 98.10 | 104.26 | 44.06 |
| 3 |
| 67.00 | 5.06 | 32.03 | 95.59 | 44.35 | 64.63 |
| 4 |
| 60.15 | 4.02 | 46.16 | 94.67 | 36.52 | 34.92 |
| 5 |
| 57.51 | 3.71 | 85.11 | 89.10 | 17.34 | 78.21 |
| 6 |
| 53.21 | 3.27 | 94.03 | 87.24 | 14.67 | 72.39 |
Fig. 3Chromatograms of Carvedilol after incubation with immobilized-cell cultures and immobilized-enzyme. a Sphingomonas paucimobilis; b C. elegans; c P. putida; d Streptomyces halstedii; e E. coli; f A. niger; g Lipase AP6 enzyme
Enantiomeric purity of Carvedilol after incubation with free- and immobilized-enzyme
| S. no. | Time interval (h) | Enantiomeric excess ( | |
|---|---|---|---|
| Free-enzyme | Immobilized-enzyme | ||
| 1 | 4 | 5.93 | 7.52 |
| 2 | 8 | 12.35 | 14.90 |
| 3 | 12 | 28.87 | 41.56 |
| 4 | 16 | 53.56 | 69.74 |
| 5 | 20 | 82.94 | 99.02 |
| 6 | 24 | 83.66 | 99.08 |